Redeemable Preferred Stock - Additional Information (Details) - USD ($) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
May 02, 2023 |
Mar. 31, 2023 |
Apr. 30, 2025 |
Apr. 30, 2024 |
Mar. 07, 2025 |
May 31, 2022 |
|
| Temporary Equity [Line Items] | ||||||
| Existing share capital | 0 | 5,000,000 | ||||
| Common stock, par value | $ 1 | $ 0.01 | ||||
| Number of preferred shares issued | 0 | |||||
| Outstanding preferred stock | $ 177,110,000 | |||||
| Redeemable Preferred Stock | ||||||
| Temporary Equity [Line Items] | ||||||
| Redeemable preferred stock, description | In May 2022, Intermediate Holdings amended and restated its Memorandum and Articles of Association, according to which Intermediate Holdings’ existing share capital of 5,000,000 shares can upon the discretion of Intermediate Holdings be issued in the form of either common and/or preferred stock with a par value of $0.01 each.For the years ended April 30, 2025 and 2024, Intermediate Holdings issued to West Affum LP a total of 103,400 and 75,000 shares of preferred stock for proceeds of $103,400 and $75,000, respectively. Following the Organizational Transactions, pre-existing interests in Intermediate Holdings, as well as non-controlling interests of its subsidiaries, were exchanged into Common Shares. Kestra Medical Technologies, Ltd. now directly owns 100% of Intermediate Holdings and indirectly owns 100% of each of Intermediate Holdings’ direct and indirect subsidiaries. There were no shares of preferred stock outstanding as of April 30, 2025. Outstanding preferred stock was $177,110 as of April 30, 2024.Preferred stock issued is considered non-voting and is subject to a preferred dividend accrued daily with a set payment “yield” capped at 4.7% for issuances prior to April 30, 2023 and at 6.0% for issuances on or after May 1, 2023. | |||||
| Existing share capital | 5,000,000 | |||||
| Redeemable preferred stock, par value | $ 0.01 | |||||
| Common stock, par value | $ 0.01 | |||||
| Percentage of preferred dividend | 6.00% | 4.70% | ||||
| Dividends declared | $ 0 | $ 0 | ||||
| Number of preferred shares issued | 103,400 | 75,000 | ||||
| Outstanding preferred stock | $ 177,110,000 | |||||
| Proceeds from issuance preferred shares | $ 103,400,000 | $ 75,000,000 | ||||
| Redeemable Preferred Stock | Directly Owns | Kestra Medical Technologies, Ltd | ||||||
| Temporary Equity [Line Items] | ||||||
| Percentage of ownership of common shares | 100.00% | |||||
| Redeemable Preferred Stock | Indirectly Owns | Kestra Medical Technologies, Ltd | ||||||
| Temporary Equity [Line Items] | ||||||
| Percentage of ownership of common shares | 100.00% | |||||
| IPO | Directly Owns | Kestra Medical Technologies, Ltd | ||||||
| Temporary Equity [Line Items] | ||||||
| Percentage of ownership of common shares | 100.00% | |||||
| IPO | Indirectly Owns | Kestra Medical Technologies, Ltd | ||||||
| Temporary Equity [Line Items] | ||||||
| Percentage of ownership of common shares | 100.00% | |||||